Use of statins and the risk of death in patients with prostate cancer.

By O. Yu, M. Eberg, S. Benayoun, A. Aprikian, G. Batist, S. Suissa, L. Azoulay. Journal of Clinical Oncology, 2014

674 citations recorded by the source corpus.

Subfields: Cancer Research, Psychiatry and Mental health, Surgery

View Paper: https://www.semanticscholar.org/paper/25bdcd819fe453fba370f5a4b6edb4eef1304fae

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. J. Armitage
2. George Davey Smith
3. R. Collins
4. M. Law
5. D. Leroith
6. P. Ridker

In Surgery

1. J. Armitage
2. George Davey Smith
3. R. Collins
4. M. Law
5. E. Gallagher
6. D. Leroith
7. P. Ridker
8. I. Graham

Citations in the corpus

• Interpretation of the evidence for the efficacy and safety of statin therapy. (2016, result): “lower rate of cancer-related mortality after adjustment for the potential confounding factors that had been recorded(90) and, in some other observational studies,(136) with as much as a halving in colon cancer incidence and in prostate cancer mortality.(137,138) By contrast, there were small excesse”
• Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. (2015, background): “Recent studies have reported that cholesterol-lowering therapy, with 3-hydroxy-3-methyl-glutaryl-CoA (HMG CoA) reductase inhibitors, is associated with a lower risk of overall cancer mortality (145), with some studies reporting a lowering risk of developing specific cancers, including hepatocellular”